A Single-Blind, Randomized, Positive-controlled Study to Compare Monotherapy With an Inhaled Corticosteroid (Mometasone) to Combination Therapy With an Inhaled Corticosteroid + a Long-Acting Bronchodilator (Advair) in Patients With Milder Persistent Asthma
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Mometasone (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 19 Sep 2017 Status changed from recruiting to discontinued.